Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation

BACKGROUND: Previous models of Hospital at Home (HAH) for COPD exacerbation (ECOPD) were limited by the lack of a reliable prognostic score to guide patient selection. Approximately 50% of hospitalised patients have a low mortality risk by DECAF, thus are potentially suitable. METHODS: In a non-infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Echevarria, Carlos, Gray, Joanne, Hartley, Tom, Steer, John, Miller, Jonathan, Simpson, A John, Gibson, G John, Bourke, Stephen C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Chronic Obstructive Pulmonary Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204956/
https://www.ncbi.nlm.nih.gov/pubmed/29680821
http://dx.doi.org/10.1136/thoraxjnl-2017-211197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204956/
https://www.ncbi.nlm.nih.gov/pubmed/29680821
http://dx.doi.org/10.1136/thoraxjnl-2017-211197

Ejemplares similares